CPT® Code 87527

The CPT® Code 87527 refers to a laboratory test designed for the detection of the hepatitis G virus (HGV), also known as GB virus-C (GBV-C), through the analysis of nucleic acids, specifically DNA or RNA. This test is crucial for identifying the presence of the infectious agent in a blood sample. Hepatitis G infection is typically asymptomatic, meaning that individuals may not exhibit noticeable symptoms, and it rarely leads to hepatic inflammation. However, it is often found in conjunction with other viral infections that can cause acute or chronic hepatitis, making its detection important in the context of co-infections. The transmission of HGV occurs primarily through infected blood and blood products, from mother to infant during childbirth, and through sexual contact between partners. The testing process involves a direct probe test, which identifies a unique nucleic acid sequence known as the target sequence of the hepatitis G virus, if it exists in the blood sample. This probe is labeled with either fluorescent or chemiluminescent markers to facilitate detection. The sample undergoes treatment to release nucleic acids from the target organism, allowing the labeled probe to specifically bind to the matching target sequence, forming a stable hybrid. Ribosomal RNA is often the focus of these tests due to its abundance in microorganisms, as it is typically present in thousands of copies compared to the limited copies of genomic DNA. To enhance the sensitivity of the assay, an amplified probe technique is employed, which involves exponentially multiplying the target sequence of hepatitis G virus DNA or RNA into millions of copies. The polymerase chain reaction (PCR) or reverse transcriptase polymerase chain reaction (RT-PCR) is the most commonly utilized amplification method. Following amplification, the replicated sequences are identified using labeled DNA probes. The nucleic acid detection process, particularly with quantification, provides valuable information regarding the number of microorganisms present in the sample. Quantitative or real-time PCR is frequently used to amplify the isolated nucleic acid segment and generate detailed reports that document the absolute or relative amounts of the known nucleic acid sequence, thereby offering insights into the viral load present in the patient’s sample.